119 related articles for article (PubMed ID: 12897821)
1. Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity.
Chen YX; O'Brien ER
Can J Physiol Pharmacol; 2003 Jul; 81(7):730-9. PubMed ID: 12897821
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
3. Na(+)-H+ exchange inhibitors decrease neointimal formation after rat carotid injury. Effects on smooth muscle cell migration and proliferation.
Mitsuka M; Nagae M; Berk BC
Circ Res; 1993 Aug; 73(2):269-75. PubMed ID: 8392448
[TBL] [Abstract][Full Text] [Related]
4. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
Whitley BR; Church FC
Int J Oncol; 2005 Sep; 27(3):749-57. PubMed ID: 16077925
[TBL] [Abstract][Full Text] [Related]
5. N-3 long-chain polyunsaturated fatty acids inhibit smooth muscle cell migration by modulating urokinase plasminogen activator receptor through MEK/ERK-dependent and -independent mechanisms.
Whyte C; Thies F; Peyrol L; Balcerzak D
J Nutr Biochem; 2012 Nov; 23(11):1378-83. PubMed ID: 22221673
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and preliminary evaluation of amiloride analogs as inhibitors of the urokinase-type plasminogen activator (uPA).
Matthews H; Ranson M; Tyndall JD; Kelso MJ
Bioorg Med Chem Lett; 2011 Nov; 21(22):6760-6. PubMed ID: 21978672
[TBL] [Abstract][Full Text] [Related]
7. Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration.
Walker J; Undem C; Yun X; Lade J; Jiang H; Shimoda LA
Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009277
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta is activated by plasmin and inhibits smooth muscle cell death in human saphenous vein.
George SJ; Johnson JL; Smith MA; Angelini GD; Jackson CL
J Vasc Res; 2005; 42(3):247-54. PubMed ID: 15870504
[TBL] [Abstract][Full Text] [Related]
9. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
10. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration.
Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ
J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275
[TBL] [Abstract][Full Text] [Related]
11. Protease-mediated human smooth muscle cell proliferation by urokinase requires epidermal growth factor receptor transactivation by triple membrane signaling.
Duru EA; Fu Y; Davies MG
J Surg Res; 2014 Dec; 192(2):254-62. PubMed ID: 25082749
[TBL] [Abstract][Full Text] [Related]
12. Pitavastatin attenuates the PDGF-induced LR11/uPA receptor-mediated migration of smooth muscle cells.
Jiang M; Bujo H; Zhu Y; Yamazaki H; Hirayama S; Kanaki T; Shibasaki M; Takahashi K; Schneider WJ; Saito Y
Biochem Biophys Res Commun; 2006 Oct; 348(4):1367-77. PubMed ID: 16919601
[TBL] [Abstract][Full Text] [Related]
13. Effect of pulse pressure on vascular smooth muscle cell migration: the role of urokinase and matrix metalloproteinase.
Redmond EM; Cahill PA; Hirsch M; Wang YN; Sitzmann JV; Okada SS
Thromb Haemost; 1999 Feb; 81(2):293-300. PubMed ID: 10064009
[TBL] [Abstract][Full Text] [Related]
14. Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.
Wang X; Jiang Z; An J; Mao X; Lin F; Sun P
Mol Med Rep; 2018 Mar; 17(3):4273-4280. PubMed ID: 29328476
[TBL] [Abstract][Full Text] [Related]
15. T-cell lymphokines, interleukin-4 and gamma interferon, modulate the induction of vascular smooth muscle cell tissue plasminogen activator and migration by serum and platelet-derived growth factor.
Wang W; Chen HJ; Giedd KN; Schwartz A; Cannon PJ; Rabbani LE
Circ Res; 1995 Dec; 77(6):1095-106. PubMed ID: 7586221
[TBL] [Abstract][Full Text] [Related]
16. Intracellular pH changes in human aortic smooth muscle cells in response to fluid shear stress.
Stamatas GN; Patrick CW; McIntire LV
Tissue Eng; 1997; 3(4):391-403. PubMed ID: 11543590
[TBL] [Abstract][Full Text] [Related]
17. UPA promotes lipid-loaded vascular smooth muscle cell migration through LRP-1.
Lugano R; Peña E; Casani L; Badimon L; Padró T
Cardiovasc Res; 2013 Nov; 100(2):262-71. PubMed ID: 23812296
[TBL] [Abstract][Full Text] [Related]
18. Domain-dependent action of urokinase on smooth muscle cell responses.
Tanski WJ; Fegley AJ; Roztocil E; Davies MG
J Vasc Surg; 2004 Jan; 39(1):214-22. PubMed ID: 14718842
[TBL] [Abstract][Full Text] [Related]
19. Ethanol inhibits pulse pressure-induced vascular smooth muscle cell migration by differentially modulating plasminogen activator inhibitor type 1, matrix metalloproteinase-2 and -9.
Cullen JP; Sayeed S; Kim Y; Theodorakis NG; Sitzmann JV; Cahill PA; Redmond EM
Thromb Haemost; 2005 Sep; 94(3):639-45. PubMed ID: 16268483
[TBL] [Abstract][Full Text] [Related]
20. T cell lymphokines modulate bFGF-induced smooth muscle cell fibrinolysis and migration.
Wang W; Chen HJ; Schwartz A; Cannon PJ; Rabbani LE
Am J Physiol; 1997 Feb; 272(2 Pt 1):C392-8. PubMed ID: 9124280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
